UK-based Porton Biopharma has begun the construction of a new pharmaceutical development facility, which will provide state-of–the–art facilities for its teams of scientists. The 530 square meter building has been designed to reflect modern best practice in laboratory design and will replace older facilities. The new facility will feature a fermentation suite with a range of bench-scale reactors and a down-stream processing suite for activities such as filtration and chromatography, all supporte...